Search results

PII: S0003-3472(05)80525-1 Anim. Behav., 1990, 40, 453~461 Asymmetric contests over resources for survival and migration: a field experiment with bluethroats A K E L I N D S T R O M , D E N N I S H A S S E L Q U I S T , S T A F F A N B E N S C H & M A T S G R A H N Department of Ecology, University of Lund, Ecology Building, S-223 62 Lund, Sweden Abstract. The relative importance of prior occupanc

https://www.luvre.lu.se/sites/luvre.lu.se/files/luvre-084lindstrommflblahakefettning.pdf - 2026-05-07

Postadress Box 7080, 22007 Lund Besöksadress Tycho Brahes väg 1 Telefon: växel 046-222 00 00 E-post förnamn.efternamn@nek.lu.se Internet http://www.nek.lu.se Nationalekonomiska inst i tut ionen Välkommen till vårens kurser i nationalekonomi på avancerad nivå Vi tycker det är mycket trevligt att du har valt att fortsätta dina studier i nationalekonomi och hoppas du ska finna den kommande terminen i

https://www.ehl.lu.se/sites/ehl.lu.se/files/2024-12/Komplett-avancerad-VT25.pdf - 2026-05-07

CFE WP nr 21 1The Principle of State Liability The Principle of State Liability The Creation of a General Principle of Law to Enhance Effective Judicial Protection of Individual EC Rights Matilda Rotkirch mrotkirch@hotmail.com 2 CFE Working paper series no. 21 CENTRE FOR EUROPEAN STUDIES AT LUND UNIVERSITY: Box 52 Phone: +46 (0)46-222 88 99 SE-221 00 LUND Fax: +46 (0)46-222 40 06 Sweden Email: cfe

https://www.cfe.lu.se/en/sites/cfe.lu.se.en/files/2020-12/cfewp21.pdf - 2026-05-07

EIT Climate-KIC Informing our 2018 Call for Proposals December 2017 Priorities 1 EIT Climate-KIC 2018 Priorities Contents A. Purpose ........................................................................................................................................... 2 B. Context ..................................................................................................................

https://www.climate-kic.lu.se/sites/climate-kic.lu.se/files/eit_climate-kic_priorities_2018_v1-5-min.pdf - 2026-05-07

HANNAH ELIZABETH HERDE Fysiska institutionen, Hus K, K326 · Professorsgatan 1 · 22363 Lund Sweden 0000-0001-8926-6734 󱿀 +1 (203) 912-1242 󱾘 hannah.herde@cern.ch 󲀥 tropicaheh 󱽚 hherde.web.cern.ch/hherde 󲄗 hherde WORK HISTORY & EDUCATION Lund University, SE 2022-present Associate Senior Lecturer in Experimental Particle Physics June 2022-present Research topics: Silicon tracking detectors (ATLA

https://www.particle-nuclear.lu.se/sites/particle-nuclear.lu.se/files/2024-04/CV_HannahHerde.pdf - 2026-05-07

Psykologiska rapporter från Lund Volym 6, Nr. 1, 2013 Åsikter och engagemang i samhällsfrågor Resultat från en webbundersökning Emma A. Bäck, Hanna Bäck, Henry Montgomery och Felix Funck Institutionen för psykologi, Lunds universitet Psykologiska rapporter från Lund Redaktör: Magnus Lindgren ISSN 1404-8124 Åsikter och engagemang i samhällsfrågor – Bäck, Bäck, Montgomery & Funck 2 Åsikter och engag

https://www.psy.lu.se/sites/psy.lu.se/files/popularvetenskaplig.rapport_v4.pdf - 2026-05-07

Signal transducer and activator of transcription 3 (STAT3) is known to be involved in the progression of prostate cancer (PCa) and is a key factor in drug resistance and tumor immunoescape. As a result, it represents a promising target for PCa therapy. We studied the effects of the STAT3 inhibitor galiellalactone (GL) on tumor growth and metastatic spread in vitro and in vivo. The effect of GL on

Elevated γ-Glutamyltransferase serum levels are associated with increased risk of overall cancer incidence and several site-specific malignancies. In the present prospective study we report on the associations of serum γ-Glutamyltransferase with the risk of breast cancer in a pooled population-based cohort considering established life style risk factors.

ABSTRACT: BACKGROUND: There is an insufficient number of reliable prognostic and response predictive biomarkers in colorectal cancer (CRC) management. In a previous study, we found that high tumour tissue expression of tumour-associated trypsin inhibitor (TATI) correlated with liver metastasis and an impaired prognosis in CRC. The aim of this study was to investigate the prognostic validity of ser

In clinical genetic diagnostics, it is difficult to predict whether genetic mutations that do not greatly alter the primary sequence of the encoded protein causing unknown functional effects on cognate proteins lead to development of disease. Here, we report the clinical identification of c.2038 T>C missense mutation in exon 18 of the human MLH1 gene and biochemically characterization of the p.Cys

Galiellalactone is a potent and specific inhibitor of STAT3 signaling which has been shown to possess growth inhibitory effects on prostate cancer cells expressing active STAT3. In this study we aimed to investigate the effect of galiellalactone on prostate cancer stem cell-like cells. We explored the expression of aldehyde dehydrogenase (ALDH) as a marker for cancer stem cell-like cells in differ

Angiosarcoma is a rare complication of breast cancer treatment. In order to define predictors, clinical presentation, and outcome, we characterized a population-based 50-year cohort of angiosarcomas after breast cancer. Clinical data were collected from all females with previous breast cancer who developed angiosarcomas/lymphangiosarcomas on the thoracic wall/upper extremity between 1958 and 2008

Having performed analytical validation studies, we are now assessing the clinical utility of the upgraded automated Bone Scan Index (BSI) in metastatic castration-resistant prostate cancer (mCRPC). In the present study, we retrospectively evaluated the discriminatory strength of the automated BSI in predicting overall survival (OS) in mCRPC patients being treated with enzalutamide.

The transcription factor STAT3 is a potential target for the treatment of castration-resistant prostate cancer. Galiellalactone (1), a direct inhibitor of STAT3, prevents the transcription of STAT3 regulated genes. In this study we characterized 6 (GPA512, Johansson, M.; Sterner, O. Patent WO 2015/132396 A1, 2015), a prodrug of 1. In vitro studies showed that 6 is rapidly converted to 1 in plasma

Prostate cancer patients with high WNT5A expression in their tumors have been shown to have more favorable prognosis than those with low WNT5A expression. This suggests that reconstitution of Wnt5a in low WNT5A-expressing tumors might be an attractive therapeutic approach. To explore this idea, we have in the present study used Foxy-5, a WNT5A mimicking peptide, to investigate its impact on primar

Breast cancer risk is influenced by rare coding variants in susceptibility genes, such as BRCA1, and many common, mostly non-coding variants. However, much of the genetic contribution to breast cancer risk remains unknown. Here we report the results of a genome-wide association study of breast cancer in 122,977 cases and 105,974 controls of European ancestry and 14,068 cases and 13,104 controls of

To analyse oncological and functional outcomes 12 months after treatment of very low risk prostate cancer with radical prostatectomy in men who could have been candidates for active surveillance.

BACKGROUND: The aim of this retrospective matched cohort study was to evaluate the rate of recurrence among women with delayed large flap breast reconstruction after mastectomy for breast cancer. The recurrence rate among women treated at a single hospital was compared with that in an individually matched control group of women with breast cancer who did not have reconstruction after mastectomy. M